They also discuss how IGFBP-1 protein concentrations and insulin sensitivity might serve an inhibitory effect of hyperinsulinemia on hepatic IGFBP-1 synthesis from the liver; suggesting IGFBP-1 transcription in insulin resistant individuals is sensitive to plasma insulin levels. The gene discussed is IGFBP1; the disease is hyperinsulinism.